Markets › United States › NAS › IMDX

Insight Molecular Diagnostics Inc

NAS:IMDXHealthcarenasdaq_composite

$2.77−2.46%LiveIn session · ≈ AED 10.17 · Market cap $90.65M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−52.5%	64.6%	−1.9%	27.5%	39.3%	4.7%	—	—
Operating margin	−2,443.3%	−2,444.3%	−1,878.6%	−1,672.4%	−3,245.1%	−754.1%	−754.1%	+0.0 pts
Net margin	−2,461.5%	−2,916.2%	−7,609.8%	−1,848.4%	−3,225.0%	−1,238.5%	−1,238.5%	+0.0 pts
EBITDA margin	−2,511.5%	−2,204.6%	−1,389.2%	−1,538.5%	−3,137.4%	−1,181.7%	—	—
Return on equity	−89.4%	−98.3%	−184.1%	−135.7%	494.2%	159.6%	159.6%	+0.0 pts
Return on assets	−54.0%	−40.2%	−72.8%	−37.1%	−172.9%	−195.0%	−195.0%	+0.0 pts
Return on capital employed	−64.0%	−36.9%	−20.5%	−37.1%	−219.5%	−223.5%	—	—
Debt / equity	0.3×	0.1×	0.1×	0.1×	−0.3×	−0.1×	−0.1×	+0.0%
Debt / assets	15.6%	3.6%	3.5%	3.8%	10.4%	13.6%	—	—
Interest coverage	−117.9×	−257.1×	−216.8×	−483.4×	−726.7×	−280.5×	—	—
Current ratio	1.0×	2.8×	2.1×	1.5×	1.6×	1.3×	1.3×	+0.0%
Quick ratio	1.0×	2.8×	2.1×	1.5×	1.6×	1.2×	—	—
Cash ratio	0.8×	2.3×	1.7×	1.3×	1.2×	1.0×	1.0×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.1×	0.2×	—	—
Inventory turnover	—	2.6×	—	—	2.8×	8.7×	—	—
Receivables turnover	6.0×	1.5×	0.5×	3.1×	1.2×	3.6×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—